The global action to end smoking grantmaking will continue to focus on advancing health and science research for cutting-edge smoking cessation and reduced-risk solutions, with a particular focus on marginalized communities and low- and middle-income countries where smoking is most widespread.
The results were included in the review "Behavioural therapy for people with diabetes who smoke: a scoping review," published in the Journal of Primary Care and Community Health: it is now clear that persons living with diabetes are not the subject of targeted treatments and that there is ample room for progress. It seems that more structured and intensive therapies could benefit these persons in bidding farewell to cigarette smoking, while little is still known about the possible benefits of combining behavioral therapies and nicotine replacement pharmacological therapies.
Catania, April 29, 2024 - This morning, as part of the April graduation session of the Bachelor's Degree in Biotechnology at the University of Catania, four more theses on the…
But how much would harm reduction and the reduction of smoking-related diseases affect international health policy strategies? Would there be fewer hospital admissions without conventional cigarette smoke? The answer will be provided by questionnaires administered to over 3000 hospitalized patients whose smoking habits and potential use of non-combustion products will be analyzed to assess the causes of hospital admission and the subsequent outcomes of the diseases identified.
Currently engaged in her internship at the laboratory of Prof. Massimo Caruso, co-project leader of the Replica project, Chiara Giardina, thanks to the work conducted in the laboratories of CoEHAR in Catania, managed to participate in and obtain the KAC scholarship.
Dr. Nikolina Kastratovic of the Faculty of Medical Sciences at the University of Kragujevac, Serbia, was honored with the award for her outstanding project on the immunomodulatory effects of combustible and electronic cigarettes on human cells.
The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms.
According to the studies, “CoEHAR research in patients with COPD patients, asthma, high blood pressure, schizophrenia show clear benefits with objective evidence for harm reversal after switching from smoking.. and also showed that lung function and respiratory symptoms and muco-ciliary clearance improve after switching from smoking to vaping”.
Jeffrey Zamora, President of Asovape Costa Rica, President of ARDT Iberoamerica and Veritas's project leader, said: "We are using an innovative platform with a 2-step verification process where people will enroll in the study. After registering on the website, participants will be asked to provide information about the devices used, frequency of use, age of initiation, flavor preferences, motivations, and any cigarette consumption or experimentation. They will also complete the Respiratory Symptom Experience Scale, a validated scale that asks subjects to rate the frequency with which they had experienced any respiratory symptoms".
“We would like to thank all the partners for accepting to continue this important partnership with the new edition of the Replica Project” stated Prof. Giovanni Li Volti, recently reconfirmed COEHAR Director “The goal for this new session of experiments is to replicate published scientific works dealing with the impact of cigarette smoke and RRP on the progression of cancer and in particular to molecular mechanisms of chemoresistance. In particular, the result of such studies will make also the difference in terms of harm reduction strategies for a particular vulnerable population of patients and improve the quality of their life in terms of life expectancy and adverse reactions to chemotherapy”
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.